Birdwatch Note
2024-01-18 17:58:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
La sobredosis de extasis puede ser letal. La morbimortalidad por éxtasis se debe a la hipertermia fulminante, arritmia cardíaca, coagulación intravascular diseminada, rabdomiolisis, insuficiencia renal aguda y toxicidad hepática. https://www.elsevier.es/es-revista-trastornos-adictivos-182-articulo-extasis-34-metilendioximetanfetamina-mdma-aspectos-farmacologicos-13056394
Written by 9742355DA8FC1E0D03506F3D1A64AD702B37BE607B6DB80BD522ACB3443633C7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1747826074489102354
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1748042169556816351
- noteId - 1748042169556816351
- participantId -
- noteAuthorParticipantId - 9742355DA8FC1E0D03506F3D1A64AD702B37BE607B6DB80BD522ACB3443633C7 Participant Details
- createdAtMillis - 1705600704932
- tweetId - 1747826074489102354
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La sobredosis de extasis puede ser letal. La morbimortalidad por éxtasis se debe a la hipertermia fulminante, arritmia cardíaca, coagulación intravascular diseminada, rabdomiolisis, insuficiencia renal aguda y toxicidad hepática. https://www.elsevier.es/es-revista-trastornos-adictivos-182-articulo-extasis-34-metilendioximetanfetamina-mdma-aspectos-farmacologicos-13056394
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-01-18 17:58:24 UTC (1705600704932) |
2024-01-18 20:25:19 UTC (1705609519580) |
CURRENTLY_RATED_HELPFUL | 2024-01-19 12:24:59 UTC (1705667099335) |
CURRENTLY_RATED_HELPFUL | 2024-01-18 20:25:19 UTC (1705609519580) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-01-19 05:17:07 -0600 | Rating Details | |
| 2024-01-19 03:30:39 -0600 | Rating Details | |
| 2024-01-19 01:13:24 -0600 | Rating Details | |
| 2024-01-18 22:24:10 -0600 | Rating Details | |
| 2024-01-18 21:54:56 -0600 | Rating Details | |
| 2024-01-18 21:47:27 -0600 | Rating Details | |
| 2024-01-18 21:31:19 -0600 | Rating Details | |
| 2024-01-18 20:28:23 -0600 | Rating Details | |
| 2024-01-18 20:00:02 -0600 | Rating Details | |
| 2024-01-18 18:41:43 -0600 | Rating Details | |
| 2024-01-18 18:35:03 -0600 | Rating Details | |
| 2024-01-18 18:34:31 -0600 | Rating Details | |
| 2024-01-18 18:01:59 -0600 | Rating Details | |
| 2024-01-18 17:31:00 -0600 | Rating Details | |
| 2024-01-18 17:10:16 -0600 | Rating Details | |
| 2024-01-18 16:53:42 -0600 | Rating Details | |
| 2024-01-18 16:34:20 -0600 | Rating Details | |
| 2024-01-18 16:33:37 -0600 | Rating Details | |
| 2024-01-18 15:52:05 -0600 | Rating Details | |
| 2024-01-18 15:50:22 -0600 | Rating Details | |
| 2024-01-18 15:30:59 -0600 | Rating Details | |
| 2024-01-18 15:11:36 -0600 | Rating Details | |
| 2024-01-18 15:05:28 -0600 | Rating Details | |
| 2024-01-18 14:54:41 -0600 | Rating Details | |
| 2024-01-18 14:49:54 -0600 | Rating Details | |
| 2024-01-18 14:37:50 -0600 | Rating Details | |
| 2024-01-18 14:34:57 -0600 | Rating Details | |
| 2024-01-18 14:32:59 -0600 | Rating Details | |
| 2024-01-18 14:28:04 -0600 | Rating Details | |
| 2024-01-18 14:05:38 -0600 | Rating Details | |
| 2024-01-18 13:45:35 -0600 | Rating Details | |
| 2024-01-18 13:43:38 -0600 | Rating Details | |
| 2024-01-18 13:36:48 -0600 | Rating Details | |
| 2024-01-18 13:31:16 -0600 | Rating Details | |
| 2024-01-18 13:27:42 -0600 | Rating Details | |
| 2024-01-18 13:27:14 -0600 | Rating Details | |
| 2024-01-18 13:14:48 -0600 | Rating Details | |
| 2024-01-18 13:08:16 -0600 | Rating Details | |
| 2024-01-18 13:02:06 -0600 | Rating Details | |
| 2024-01-18 12:57:13 -0600 | Rating Details | |
| 2024-01-18 12:56:27 -0600 | Rating Details | |
| 2024-01-18 12:50:06 -0600 | Rating Details | |
| 2024-01-18 12:39:24 -0600 | Rating Details | |
| 2024-01-18 12:38:22 -0600 | Rating Details | |
| 2024-01-18 12:35:56 -0600 | Rating Details | |
| 2024-01-18 12:31:17 -0600 | Rating Details | |
| 2024-01-18 12:15:43 -0600 | Rating Details | |
| 2024-01-18 12:12:06 -0600 | Rating Details | |
| 2024-01-18 12:10:03 -0600 | Rating Details | |
| 2024-01-18 12:07:16 -0600 | Rating Details | |
| 2024-01-18 12:04:43 -0600 | Rating Details | |
| 2024-01-19 08:58:41 -0600 | Rating Details | |
| 2024-01-19 08:23:26 -0600 | Rating Details | |
| 2024-01-19 04:47:34 -0600 | Rating Details | |
| 2024-01-18 22:13:53 -0600 | Rating Details | |
| 2024-01-18 22:08:24 -0600 | Rating Details | |
| 2024-01-18 21:18:47 -0600 | Rating Details | |
| 2024-01-18 20:54:05 -0600 | Rating Details | |
| 2024-01-18 20:16:15 -0600 | Rating Details | |
| 2024-01-18 19:35:57 -0600 | Rating Details | |
| 2024-01-18 19:29:06 -0600 | Rating Details | |
| 2024-01-18 18:44:46 -0600 | Rating Details | |
| 2024-01-18 18:40:48 -0600 | Rating Details | |
| 2024-01-18 17:58:23 -0600 | Rating Details | |
| 2024-01-18 17:44:10 -0600 | Rating Details | |
| 2024-01-18 17:38:40 -0600 | Rating Details | |
| 2024-01-18 17:03:37 -0600 | Rating Details | |
| 2024-01-18 17:00:09 -0600 | Rating Details | |
| 2024-01-18 16:45:42 -0600 | Rating Details | |
| 2024-01-18 16:36:07 -0600 | Rating Details | |
| 2024-01-18 16:23:34 -0600 | Rating Details | |
| 2024-01-18 16:01:42 -0600 | Rating Details | |
| 2024-01-18 16:00:02 -0600 | Rating Details | |
| 2024-01-18 15:23:55 -0600 | Rating Details | |
| 2024-01-18 14:47:39 -0600 | Rating Details | |
| 2024-01-18 14:23:35 -0600 | Rating Details | |
| 2024-01-18 14:22:30 -0600 | Rating Details | |
| 2024-01-18 14:13:41 -0600 | Rating Details | |
| 2024-01-18 13:45:03 -0600 | Rating Details | |
| 2024-01-18 13:37:27 -0600 | Rating Details | |
| 2024-01-18 13:34:52 -0600 | Rating Details | |
| 2024-01-18 13:32:35 -0600 | Rating Details | |
| 2024-01-18 13:04:05 -0600 | Rating Details | |
| 2024-01-18 12:57:07 -0600 | Rating Details | |
| 2024-01-18 12:56:22 -0600 | Rating Details | |
| 2024-01-18 12:50:31 -0600 | Rating Details | |
| 2024-01-18 12:47:29 -0600 | Rating Details | |
| 2024-01-18 12:40:16 -0600 | Rating Details | |
| 2024-01-18 12:35:49 -0600 | Rating Details | |
| 2024-01-18 12:30:42 -0600 | Rating Details | |
| 2024-01-18 12:29:16 -0600 | Rating Details | |
| 2024-01-18 12:28:02 -0600 | Rating Details | |
| 2024-01-18 12:24:27 -0600 | Rating Details | |
| 2024-01-18 12:23:42 -0600 | Rating Details | |
| 2024-01-18 12:23:12 -0600 | Rating Details | |
| 2024-01-18 12:21:14 -0600 | Rating Details | |
| 2024-01-18 12:20:42 -0600 | Rating Details | |
| 2024-01-18 12:19:24 -0600 | Rating Details | |
| 2024-01-18 12:17:54 -0600 | Rating Details | |
| 2024-01-18 12:10:15 -0600 | Rating Details | |
| 2024-01-18 12:08:39 -0600 | Rating Details | |
| 2024-01-18 12:04:47 -0600 | Rating Details | |
| 2024-01-22 10:19:40 -0600 | Rating Details | |
| 2024-01-22 00:56:17 -0600 | Rating Details | |
| 2024-01-21 11:16:20 -0600 | Rating Details | |
| 2024-01-26 09:26:28 -0600 | Rating Details | |
| 2024-01-25 21:26:38 -0600 | Rating Details | |
| 2024-01-25 18:17:12 -0600 | Rating Details | |
| 2024-01-25 17:16:20 -0600 | Rating Details | |
| 2024-01-25 14:30:10 -0600 | Rating Details | |
| 2024-01-25 13:40:07 -0600 | Rating Details | |
| 2024-01-25 12:10:39 -0600 | Rating Details | |
| 2024-01-25 11:46:28 -0600 | Rating Details | |
| 2024-01-25 10:53:30 -0600 | Rating Details | |
| 2024-01-25 10:42:36 -0600 | Rating Details | |
| 2024-01-25 10:28:34 -0600 | Rating Details | |
| 2024-01-25 03:05:16 -0600 | Rating Details | |
| 2024-01-23 06:41:14 -0600 | Rating Details | |
| 2024-01-18 19:38:47 -0600 | Rating Details | |
| 2024-01-29 00:56:49 -0600 | Rating Details | |
| 2024-02-01 13:17:00 -0600 | Rating Details |